Página 3 - Melhores Carcinomatose médicos - TOP-66 médicos

Mais de 30 anos de experiência em imunologia – A Dra. Jaunalksne é especialista em viroterapia, uma abordagem de vanguarda na imunologia.

• Chefiar o Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduar-se no Instituto Médico de Riga com internato em Medicina Interna
• Focar em tratamentos inovadores de viroterapia

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Especializado em cirurgias oncológicas complexas, incluindo procedimentos de pâncreas e vias biliares nos Hospitais Büyük Anadolu.

• Especialização em cirurgia oncológica com foco em cancros gastrointestinais
• Realizar cirurgias avançadas de cancro da mama e da tiroide
• Capacitado em técnicas de cirurgia bariátrica e metabólica

O Dr. Joseba Rebollo Liceaga traz mais de 30 anos de experiência em oncologia, especializando-se em abordagens de tratamento multidisciplinares.

• Chefiar o departamento de oncologia em vários hospitais de prestígio
• Redigir pesquisas sobre eletroquimioterapia
• Especialista em Oncologia Médica na Clínica Universidad de Navarra
• Atuar atualmente na Quirónsalud Alicante

Especializado em Radioncologia pela Universidade de Marmara – uma das principais faculdades de medicina da Turquia.

• Graduar-se pela Faculdade de Medicina da Universidade de Marmara
• Concluir formação especializada em Radioncologia
• Trabalhar no Hospital Emsey – um centro de tratamento oncológico de referência

Com mais de 20 anos dedicados à hematologia e oncologia pediátricas, a Dra. Lopez Ibor lidera a Unidade de Hematologia e Oncologia Pediátrica do Hospital HM Montepríncipe.

• Especializar-se em tumores ósseos e cerebrais, leucemia e doenças hematológicas
• Formar-se na Universidade de Maryland em Hematologia e Oncologia Pediátrica
• Autora de numerosas publicações científicas nacionais e internacionais
• Anteriormente, dirigir a mesma unidade no Hospital Universitario Clínica San Rafael

Especialista em oncologia com sólida formação académica, lecionando a estudantes de medicina e liderando a investigação de pós-graduação no HM CIOCC.

• Especializar-se em oncologia oral e maxilofacial
• Lecionar uma vasta gama de disciplinas relacionadas com a oncologia
• Dirigir investigação de pós-graduação em oncologia clínica e aplicada
• Prestar tutoria a estudantes de medicina e residentes em práticas oncológicas

Mais de 30.000 exames de PET realizados e 1.000 pacientes com cancro da tiroide tratados – o Dr. Borde é especialista em medicina nuclear no HCG Manavata Cancer Centre.

• 12 anos de experiência em medicina nuclear
• Proficiente em terapias com radioiodo e Lu-177 RN
• Especialista em todos os tipos de exames nucleares e PET-CT
• Artigos publicados em diversas revistas médicas

O Dr. Sridhar P.S. é especializado em radioterapia para carcinomatose, com vasta formação em instituições de topo na Índia.

• Certificado em radioterapia com mais de 18 anos de experiência
• Membro da Society for Neuro-Oncology e do Bangalore Oncology Group
• Formado pela Banaras Hindu University e pelo National Board of Examination
• Especializar-se em técnicas de radioterapia avançada para casos de cancro complexos

A Dra. Shruti Kate é especializada em tratamentos avançados contra o câncer, incluindo imunoterapia e terapia metronômica. Ela formou-se no Tata Memorial Hospital – o principal centro de oncologia da Índia.

• Ser especialista em cancros do pulmão, da mama e ginecológicos
• Ser membro da ASCO, ESMO e outras sociedades oncológicas de topo
• Apresentar investigação sobre o cancro do pulmão na Conferência Mundial sobre o Cancro do Pulmão
• Utilizar abordagens inovadoras para casos de cancro avançado